Recursion Pharmaceuticals EBITDA per Employee

EBITDA per Employee of Recursion Pharmaceuticals is -1.30 M USD in 2026.

EBITDA per Employee of Recursion Pharmaceuticals changed from -920,408.00 USD to -1.30 M USD, representing a 40.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Recursion Pharmaceuticals historically and in real time.